130 related articles for article (PubMed ID: 25416563)
21. Anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting: a meta-analysis.
van de Kar MRD; van Brakel TJ; Van't Veer M; van Steenbergen GJ; Daeter EJ; Crijns HJGM; van Veghel D; Dekker LRC; Otterspoor LC
Eur Heart J; 2024 May; ():. PubMed ID: 38809189
[TBL] [Abstract][Full Text] [Related]
22. Impact of maintaining serum potassium concentration ≥ 3.6mEq/L versus ≥ 4.5mEq/L for 120 hours after isolated coronary artery bypass graft surgery on incidence of new onset atrial fibrillation: Protocol for a randomized non-inferiority trial.
Campbell NG; Allen E; Evans R; Jamal Z; Opondo C; Sanders J; Sturgess J; Montgomery HE; Elbourne D; O'Brien B
PLoS One; 2024; 19(3):e0296525. PubMed ID: 38478488
[TBL] [Abstract][Full Text] [Related]
23. Patterns of cytokine release and association with new onset of post-cardiac surgery atrial fibrillation.
Kota R; Gemelli M; Dimagli A; Suleiman S; Moscarelli M; Dong T; Angelini GD; Fudulu DP
Front Surg; 2023; 10():1205396. PubMed ID: 37325422
[TBL] [Abstract][Full Text] [Related]
24. Ranolazine versus amiodarone for prevention of postoperative atrial fibrillation.
Burashnikov A; Antzelevitch C
Future Cardiol; 2011 Nov; 7(6):733-7. PubMed ID: 22050058
[TBL] [Abstract][Full Text] [Related]
25. Atrial Fibrillation after Descending Aorta Repair: Occurrence, Risk Factors, and Impact on Outcomes.
Pujara AC; Koprivanac M; Stembal F; Lowry AM; Nowicki ER; Chung M; Wagoner DV; Blackstone EH; Roselli EE
Aorta (Stamford); 2023 Jun; 11(3):116-124. PubMed ID: 37619569
[TBL] [Abstract][Full Text] [Related]
26. Ranolazine Induced Bradycardia, Renal Failure, and Hyperkalemia: A BRASH Syndrome Variant.
Zaidi SAA; Shaikh D; Saad M; Vittorio TJ
Case Rep Med; 2019; 2019():2740617. PubMed ID: 31975993
[TBL] [Abstract][Full Text] [Related]
27. Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study.
De Ferrari GM; Maier LS; Mont L; Schwartz PJ; Simonis G; Leschke M; Gronda E; Boriani G; Darius H; Guillamón Torán L; Savelieva I; Dusi V; Marchionni N; Quintana Rendón M; Schumacher K; Tonini G; Melani L; Giannelli S; Alberto Maggi C; Camm AJ;
Heart Rhythm; 2015 May; 12(5):872-8. PubMed ID: 25602175
[TBL] [Abstract][Full Text] [Related]
28. Oral carvedilol in escalating doses in the acute treatment of atrial fibrillation.
Chitrapu RV; Rao PR; Reddy GV
J Pharmacol Pharmacother; 2014 Oct; 5(4):239-44. PubMed ID: 25422563
[TBL] [Abstract][Full Text] [Related]
29. Switching from nitrate therapy to ranolazine in patients with coronary artery disease receiving phosphodiesterase type-5 inhibitors for erectile dysfunction.
Udeoji DU; Schwarz ER
Clin Med Insights Case Rep; 2014; 7():131-4. PubMed ID: 25452706
[TBL] [Abstract][Full Text] [Related]
30. Postoperative atrial fibrillation: incidence, mechanisms, and clinical correlates.
Yadava M; Hughey AB; Crawford TC
Cardiol Clin; 2014 Nov; 32(4):627-36. PubMed ID: 25443241
[TBL] [Abstract][Full Text] [Related]
31. Antiarrhythmic properties of ranolazine: A review of the current evidence.
Gupta T; Khera S; Kolte D; Aronow WS; Iwai S
Int J Cardiol; 2015; 187():66-74. PubMed ID: 25828315
[TBL] [Abstract][Full Text] [Related]
32. Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease.
Allen LaPointe NM; Dai D; Thomas L; Piccini JP; Peterson ED; Al-Khatib SM
Am J Cardiol; 2015 Feb; 115(3):316-22. PubMed ID: 25491240
[TBL] [Abstract][Full Text] [Related]
33. Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the Veterans Affairs versus other hospitals: insights from the Beta-blocker Evaluation of Survival Trial (BEST).
Jones LG; Sin MK; Hage FG; Kheirbek RE; Morgan CJ; Zile MR; Wu WC; Deedwania P; Fonarow GC; Aronow WS; Prabhu SD; Fletcher RD; Ahmed A; Allman RM
Circ Heart Fail; 2015 Jan; 8(1):17-24. PubMed ID: 25480782
[TBL] [Abstract][Full Text] [Related]
34. Predictors of conversion of recent-onset atrial fibrillation treated with vernakalant.
Costabel JP; Lambardi F; Aragón M; Campos R; Urdapilleta M; Ariznavarreta P; Vergara JM; Conde D
Pacing Clin Electrophysiol; 2015 Feb; 38(2):196-200. PubMed ID: 25469647
[TBL] [Abstract][Full Text] [Related]
35. Lower loading dose of prasugrel compared with conventional loading doses of clopidogrel and prasugrel in korean patients undergoing elective coronary angiography: a randomized controlled study evaluating pharmacodynamic efficacy.
Lee DH; Kim MH; Guo LZ; Park MK; Yi SJ
Korean Circ J; 2014 Nov; 44(6):386-93. PubMed ID: 25469140
[TBL] [Abstract][Full Text] [Related]
36. Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort study.
Lee M; Wu YL; Saver JL; Lee HC; Lee JD; Chang KC; Wu CY; Lee TH; Wang HH; Rao NM; Ovbiagele B
BMJ Open; 2014 Dec; 4(12):e006672. PubMed ID: 25468508
[TBL] [Abstract][Full Text] [Related]
37. Myopathy during treatment with the antianginal drug ranolazine.
Kassardjian CD; Tian X; Vladutiu G; Wong LJ; Milone M
J Neurol Sci; 2014 Dec; 347(1-2):380-2. PubMed ID: 25466697
[TBL] [Abstract][Full Text] [Related]
38. Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT.
Yamal JM; Oparil S; Davis BR; Alderman MH; Calhoun DA; Cushman WC; Fendley HF; Franklin SS; Habib GB; Pressel SL; Probstfield JL; Sastrasinh S;
J Am Soc Hypertens; 2014 Nov; 8(11):808-19. PubMed ID: 25455006
[TBL] [Abstract][Full Text] [Related]
39. Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study.
Leoncini M; Toso A; Maioli M; Tropeano F; Badia T; Villani S; Bellandi F
Am Heart J; 2014 Nov; 168(5):792-7. PubMed ID: 25440809
[TBL] [Abstract][Full Text] [Related]
40. Hemodynamic effects of ambrisentan-tadalafil combination therapy on progressive portopulmonary hypertension.
Yamashita Y; Tsujino I; Sato T; Yamada A; Watanabe T; Ohira H; Nishimura M
World J Hepatol; 2014 Nov; 6(11):825-9. PubMed ID: 25429321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
